Testing effectiveness (Phase 2)UnknownNCT03390062What this trial is testingApatinib in Recurrent or Recurrent High-grade GliomaWho this might be right forGlioma West China Hospital 30
Early research (Phase 1)Enrolling By InvitationNCT06896110What this trial is testingIntrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade GliomaWho this might be right forGlioblastoma (GBM)Diffuse Midline Glioma (DMG)Astrocytoma, IDH-Mutant, Grade 4+2 more Andrew P. Groves 34
Early research (Phase 1)Study completedNCT03615404What this trial is testingCytomegalovirus (CMV) RNA-Pulsed Dendritic Cells for Pediatric Patients and Young Adults With WHO Grade IV Glioma, Recurrent Malignant Glioma, or Recurrent MedulloblastomaWho this might be right forGlioblastomaMalignant GliomaMedulloblastoma Recurrent+3 more Gary Archer Ph.D. 11
Early research (Phase 1)Ended earlyNCT00006247What this trial is testingSU5416 in Treating Children With Recurrent or Progressive Brain TumorsWho this might be right forBrain and Central Nervous System Tumors Pediatric Brain Tumor Consortium 33
Early research (Phase 1)Study completedNCT05362409What this trial is testingStudy to Evaluate 5-ALA Combined With CV01 Delivery of Ultrasound in Recurrent High Grade GliomaWho this might be right forHigh Grade Glioma Alpheus Medical, Inc. 22
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07521657What this trial is testingEfficacy of Mirdametinib Alone or Combination With Radiotherapy for Germline and Sporadic NF1-Altered High-Grade GliomaWho this might be right forNeurofibromatosis 1 (NF1) University of Alabama at Birmingham 55
Testing effectiveness (Phase 2)Active Not RecruitingNCT06521567What this trial is testingCobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With CancerWho this might be right forMelanomaHodgkin LymphomaHigh and Low Grade Glioma+9 more GlaxoSmithKline 83
Early research (Phase 1)Study completedNCT00363272What this trial is testingIspinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or LymphomaWho this might be right forChildhood Burkitt LymphomaChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus Tumor+22 more National Cancer Institute (NCI) 30
Early research (Phase 1)Active Not RecruitingNCT06632236What this trial is testing5G-EMERALD: Amivantamab in Malignant Brain TumoursWho this might be right forMalignant Primary GliomasGlioblastoma Multiform (Grade IV Astrocytoma)Diffuse Hemispheric Glioma, H3 G34-Mutant+1 more Institute of Cancer Research, United Kingdom 12
Testing effectiveness (Phase 2)Study completedNCT03245151What this trial is testingStudy of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System TumorsWho this might be right forRecurrent and Refractory Solid Tumors Eisai Inc. 64
Not applicableNot Yet RecruitingNCT07109362What this trial is testingERP-Based Research on the Modulation of Remimazolam on Working Memory and Brain Network Mechanisms in Glioma PatientsWho this might be right forRemimazolam Mild SedationHealthy Brain and Glioma Brain Beijing Tiantan Hospital 60
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Early research (Phase 1)Ended earlyNCT04541225What this trial is testingStudy of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid TumorsWho this might be right forGliomaGlioma, MalignantGlioma, Mixed+21 more Nuvation Bio Inc. 74
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07389278What this trial is testingCombination ADI-PEG 20, TMZ, and RT for Treatment of Newly Diagnosed High-grade Glioma (HGG)Who this might be right forGlioblastomaHigh-Grade Glioma (WHO III-IV)High-grade Glioma+2 more Sabine Mueller, MD, PhD 97
Testing effectiveness (Phase 2)Looking for participantsNCT05180825What this trial is testingPediatric Low Grade Glioma - MEKinhibitor TRIal vs ChemotherapyWho this might be right forGrade 1 GliomaMixed Glio-neuronal TumorsPleomorphic Xanthoastrocytoma University Hospital, Strasbourg, France 134
Testing effectiveness (Phase 2)Ended earlyNCT00788125What this trial is testingDasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid TumorsWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more City of Hope Medical Center 7
Very early researchLooking for participantsNCT06072586What this trial is testingBDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or FusionsWho this might be right forHigh Grade GliomaGlioblastoma St. Joseph's Hospital and Medical Center, Phoenix 82
Testing effectiveness (Phase 2)Study completedNCT01032200What this trial is testingArmodafinil in Treating Fatigue Caused By Radiation Therapy in Patients With Primary Brain TumorsWho this might be right forBrain TumorsNervous System TumorsCognition Disorders+1 more Wake Forest University Health Sciences 54
Early research (Phase 1)Study completedNCT00053118What this trial is testingChemotherapy and Stem Cell Transplantation in Treating Children With Central Nervous System CancerWho this might be right forBrain and Central Nervous System TumorsLymphomaNeuroblastoma+1 more Roswell Park Cancer Institute 1
Early research (Phase 1)Looking for participantsNCT07755397What this trial is testingFirst in Human Multicenter Open Name Dose-increase, Consolidation Method to Study Safety Drug-level in Blood & Drug Metabolism Clinical Activity of Oral JBI-778 in Lung Cancer Patients With, Without Brain Metastasis IDH Mutated WHO Grade 3,4 Recurrent Glioma, Salivary Glands TumorWho this might be right forNSCLC Patients With EGFR Activating MutationAdenoid Cystic Carcinoma MetastaticAdenoid Cystic Carcinoma of the Head and Neck Jubilant Therapeutics India Limited 30